A judge has issued a permanent injunction, signaling an Insulet (Nasdaq:PODD) victory in a trade secret case against EOFlow.

Key Takeaways Insulet announced announced Ashley McEvoy would replace Jim Hollingshead as CEO.The maker of the Omnipod ...

The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...

With a market cap of $17.2 billion, Insulet Corporation (PODD) is a leading developer and manufacturer of the Omnipod Insulin ...

Ashley McEvoy comes to Insulet having worked at the New Jersey-based healthcare company Johnson & Johnson from 1996 to 2023 ...

McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of ...

(“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its Board of Directors has appointed Ashley ...

Insulet recently launched the Omnipod 5 system in Canada, marking a noteworthy advancement in diabetes management with public reimbursement already underway in some provinces. Despite this ...

With a market cap of $17.2 billion, Insulet Corporation (PODD) is a leading developer and manufacturer of the Omnipod Insulin Management System, an innovative, tubeless, and easy-to-use ...